No Link Between Striatal Dopaminergic Axons and Dopamine Transporter Imagingin Parkinson’s Disease
: Honkanen Emma A., Saari Laura, Orte Katri, Gardberg Maria, Noponen Tommi, Joutsa Juho, Kaasinen Valtteri
Publisher: Wiley-Blackwell Publishing Ltd.
: 2019
: Movement Disorders
: 34
: 10
: 1562
: 1566
: 5
: 0885-3185
: 1531-8257
DOI: https://doi.org/10.1002/mds.27777
: https://research.utu.fi/converis/portal/detail/Publication/41652649
Background:Brain dopamine transporter binding hasbeen considered a possible biomarker for nigrostriataldegeneration in PD.Objective:To investigate whether dopamine trans-porter binding is associated with the number of dopa-minergic neurites in the putamen.
Methods:Tyrosine hydroxylase–positive nervefiberswere counted from postmortem putamen sections takenfrom 14 parkinsonism patients who had been scannedwith dopamine transporter single-photon emission com-puted tomography antemortem. Fiber counts were cor-related with putamen dopamine transporter binding andSN neuron counts.
Results:The putamen dopamine transporter specificbinding ratio did not correlate with the putamen tyrosinehydroxylase–positive axon counts (r = 0.00;P= 1.0; PDpatients: r = 0.07;P= 0.86). The nigra neuron counts had a positive correlation with the putamen tyrosinehydroxylase–positive axon counts.
Conclusions:Striatal dopamine transporter imagingdoes not associate with axonal nor somal loss of thenigrostriatal neurons in PD. It may reflect dopaminergicactivity rather than number of surviving neurons or theirstriatal projection axons.